Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-09-08 00:00:00 ET · period of report 2022-09-06 · accession 0001493152-22-025399 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-08 | 2022-09-06+ | JBIO | Dake Benjamin T | See Remarks | S - Sale+OE | $18.50 | -12.8K | 606 | -95% | -$237.3K |
| DM | 2022-09-08 | 2022-09-06+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $1.74 | +17.4K | 9,166 | New | +$30.3K |
| DM | 2022-09-08 | 2022-09-06+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $0.00 | -17.4K | 45.3K | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-07 | S | D | 4.56 | $18.12 | 3,658 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.32 to $18.32, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2022-09-07 | S | D | 3,658 | $18.42 | 0 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.345 to $18.625, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2022-09-07 | M | A | 8,220 | $1.74 | 8,220 | D | — | — | |
| 4 | Common | Common Stock | 2022-09-06 | S | D | 606 | $19.78 | 0 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.595 to $20.075, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2022-09-06 | M | A | 9,166 | $1.74 | 9,166 | D | — | — | |
| 6 | Common | Common Stock | 2022-09-06 | S | D | 4,422 | $17.94 | 4,744 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.56 to $18.50, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 7 | Common | Common Stock | 2022-09-06 | S | D | 4,138 | $18.98 | 606 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.57 to $19.50, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-09-07 | M | D | 8,220 | $0.00 | 37,128 | D | $1.74 · — to 2030-09-03 | 8,220 Common Stock | (F7) A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-09-06 | M | D | 9,166 | $0.00 | 45,348 | D | $1.74 · — to 2030-09-03 | 9,166 Common Stock | (F7) A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |